TY - GEN
T1 - A VIBROTACTILE WEARABLE FOR THE EAR FOR VAGUS NERVE STIMULATION
AU - Adams, Josh
AU - Doherty, Colton
AU - Leuthardt, Eric
AU - Gorlewicz, Jenna
N1 - Publisher Copyright:
© 2022 by ASME
PY - 2022
Y1 - 2022
N2 - Vagus Nerve Stimulation (VNS) is a therapy providing electrical stimulation directly to the vagus nerve via surgical implantation, and is currently FDA approved for the treatment of drug resistant epilepsy and depression. Transcutaneous Vagus Nerve Stimulation (taVNS) has recently been explored through electrical and vibrotactile stimulation via the cymba conchae region of the ear. taVNS is still in early testing, and is showing promise as a non-invasive alternative for VNS. However, published research has shown limitations in stimulation devices and the specific sites, frequency and intensity of taVNS treatments. In this paper, a new device for vibrotactile stimulation of the cymba conchae is presented covering a range of vibration frequencies and intensities. This is the first iteration in a series of iterative prototypes of additively manufactured wearable devices with proof of concept electronics to realize this type of vibration therapy. Functionality tests of this device such as battery performance and variability of signal intensity were explored, coupled with user assessments of comfort. Initial findings have provided critical feedback for shaping the next iteration of this device, which will be designed for use in clinical evaluations of vibration therapy of the cymba conchae.
AB - Vagus Nerve Stimulation (VNS) is a therapy providing electrical stimulation directly to the vagus nerve via surgical implantation, and is currently FDA approved for the treatment of drug resistant epilepsy and depression. Transcutaneous Vagus Nerve Stimulation (taVNS) has recently been explored through electrical and vibrotactile stimulation via the cymba conchae region of the ear. taVNS is still in early testing, and is showing promise as a non-invasive alternative for VNS. However, published research has shown limitations in stimulation devices and the specific sites, frequency and intensity of taVNS treatments. In this paper, a new device for vibrotactile stimulation of the cymba conchae is presented covering a range of vibration frequencies and intensities. This is the first iteration in a series of iterative prototypes of additively manufactured wearable devices with proof of concept electronics to realize this type of vibration therapy. Functionality tests of this device such as battery performance and variability of signal intensity were explored, coupled with user assessments of comfort. Initial findings have provided critical feedback for shaping the next iteration of this device, which will be designed for use in clinical evaluations of vibration therapy of the cymba conchae.
KW - 3D Printing
KW - Additive Manufacturing
KW - Transcutaneous Vagus Nerve Stimulation
KW - Vagus Nerve Stimulation
KW - Wearable Medical Device
KW - taVNS
UR - http://www.scopus.com/inward/record.url?scp=85130278070&partnerID=8YFLogxK
U2 - 10.1115/DMD2022-1047
DO - 10.1115/DMD2022-1047
M3 - Conference contribution
AN - SCOPUS:85130278070
T3 - Proceedings of the 2022 Design of Medical Devices Conference, DMD 2022
BT - Proceedings of the 2022 Design of Medical Devices Conference, DMD 2022
PB - American Society of Mechanical Engineers
T2 - 2022 Design of Medical Devices Conference, DMD 2022
Y2 - 11 April 2022 through 14 April 2022
ER -